T Tomita

Summary

Affiliation: Oregon Health and Science University
Country: USA

Publications

  1. ncbi Islet amyloid polypeptide in pancreatic islets from type 2 diabetic subjects
    Tatsuo Tomita
    Department of Integrative Bioscience, Oregon National Primate Center, Oregon Health and Science University, Portland, OR, USA
    Islets 4:223-32. 2012
  2. ncbi Immunocytochemical localization of lymphatic and venous vessels in colonic polyps and adenomas
    Tatsuo Tomita
    Department of Integrative Biosciences, Oregon Health and Science University, 611 SW Campus Drive, Portland, OR 97239 3097, USA
    Dig Dis Sci 53:1880-5. 2008
  3. ncbi Lymphatic vessel endothelial hyaluronan receptor 1 immunocytochemical staining for pancreatic islets and pancreatic endocrine tumors
    Tatsuo Tomita
    Department of Integrative Biosciences, Oregon Health and Science University, Portland, OR 97239 3097, USA
    Pancreas 35:e18-22. 2007
  4. ncbi LYVE-1 immunocytochemical staining for gastrointestinal carcinoids
    Tatsuo Tomita
    Department of Integrative Biosciences, Oregon National Primate Center, Oregon Health and Science University, Portland, OR 97239, USA
    Pathology 41:248-53. 2009
  5. ncbi Immunocytochemical localisation of caspase-3 in pancreatic islets from type 2 diabetic subjects
    Tatsuo Tomita
    Department of Pathology, and Oregon National Primate Center, Oregon Health and Science University, Portland, OR 97006, USA
    Pathology 42:432-7. 2010
  6. ncbi Immunocytochemical localization of cleaved caspase-3 in pancreatic islets from type 1 diabetic subjects
    Tatsuo Tomita
    Department of Integrative Biosciences, Oregon National Primate Center, Oregon Health and Science University, Portland, USA
    Islets 2:24-9. 2010
  7. ncbi Cleaved caspase-3 immunocytochemical staining for pancreatic islets and pancreatic endocrine tumors: A potential marker for biological malignancy
    Tatsuo Tomita
    Department of Integrative Biosciences, Oregon National Primate Center, Oregon Health and Science University, Portland, USA
    Islets 2:82-8. 2010
  8. ncbi Islet amyloid polypeptide in pancreatic islets from type 1 diabetic subjects
    Tatsuo Tomita
    Department of Integrative Bioscience, Oregon National Primate Center, Oregon Health and Science University, Portland, OR, USA
    Islets 3:166-74. 2011
  9. ncbi Localization of nerve fibers in colonic polyps, adenomas, and adenocarcinomas by immunocytochemical staining for PGP 9.5
    Tatsuo Tomita
    Department of Pathology and Oregon National Primate Center, Oregon Health and Science University, Portland, OR, USA
    Dig Dis Sci 57:364-70. 2012
  10. ncbi Immunocytochemical staining for islet amyloid polypeptide in pancreatic endocrine tumors
    Tatsuo Tomita
    Department of Pathology and Oregon National Primate Center, Oregon Health and Science University, Portland, OR, USA
    Islets 3:344-51. 2011

Collaborators

  • O W Tawfik
  • Akihide Tanimoto
  • Shohei Shimajiri
  • Takakazu Sasaguri
  • Yasuyuki Sasaguri
  • Yasumasa Matsuki

Detail Information

Publications23

  1. ncbi Islet amyloid polypeptide in pancreatic islets from type 2 diabetic subjects
    Tatsuo Tomita
    Department of Integrative Bioscience, Oregon National Primate Center, Oregon Health and Science University, Portland, OR, USA
    Islets 4:223-32. 2012
    ..IAPP in β-cell granules may initiate β-cell necrosis through apoptosis to form interstitial amyloid deposits in type 2 diabetic islets...
  2. ncbi Immunocytochemical localization of lymphatic and venous vessels in colonic polyps and adenomas
    Tatsuo Tomita
    Department of Integrative Biosciences, Oregon Health and Science University, 611 SW Campus Drive, Portland, OR 97239 3097, USA
    Dig Dis Sci 53:1880-5. 2008
    ..In villous adenomas, smaller lymphatic and venous vessels were noted in intervillous stroma. There are no increased lymphatic and venous vessels in intermucosal stroma and stalks of adenomas compared with normal colon...
  3. ncbi Lymphatic vessel endothelial hyaluronan receptor 1 immunocytochemical staining for pancreatic islets and pancreatic endocrine tumors
    Tatsuo Tomita
    Department of Integrative Biosciences, Oregon Health and Science University, Portland, OR 97239 3097, USA
    Pancreas 35:e18-22. 2007
    ..Pancreatic endocrine tumors were studied for LYVE-1 immunocytochemical staining compared with normal pancreatic islets to detect possible presence of LYVE-1 in PETs...
  4. ncbi LYVE-1 immunocytochemical staining for gastrointestinal carcinoids
    Tatsuo Tomita
    Department of Integrative Biosciences, Oregon National Primate Center, Oregon Health and Science University, Portland, OR 97239, USA
    Pathology 41:248-53. 2009
    ..The current study was extended to investigate possible immunostaining of gastrointestinal carcinoids using goat antihuman LYVE-1 antibody...
  5. ncbi Immunocytochemical localisation of caspase-3 in pancreatic islets from type 2 diabetic subjects
    Tatsuo Tomita
    Department of Pathology, and Oregon National Primate Center, Oregon Health and Science University, Portland, OR 97006, USA
    Pathology 42:432-7. 2010
    ..This study aimed to immunocytochemically identify cleaved caspase-3 positive islet cells in type 2 diabetic subjects compared with control subjects...
  6. ncbi Immunocytochemical localization of cleaved caspase-3 in pancreatic islets from type 1 diabetic subjects
    Tatsuo Tomita
    Department of Integrative Biosciences, Oregon National Primate Center, Oregon Health and Science University, Portland, USA
    Islets 2:24-9. 2010
    ..AIMS/ HYPOTHESIS: Caspase-3 is a main effector caspase of the apoptotic cascade. Involvement of caspase-3 has been implicated in a β cell cloned cell line from type 1 diabetic subjects and in isolated islets from type 2 diabetic subjects...
  7. ncbi Cleaved caspase-3 immunocytochemical staining for pancreatic islets and pancreatic endocrine tumors: A potential marker for biological malignancy
    Tatsuo Tomita
    Department of Integrative Biosciences, Oregon National Primate Center, Oregon Health and Science University, Portland, USA
    Islets 2:82-8. 2010
    ..This study is aimed to immunocytochemically identify cleaved caspase-3 (CC-3) positive cells in pancreatic endocrine tumors (PETs) compared with control islets...
  8. ncbi Islet amyloid polypeptide in pancreatic islets from type 1 diabetic subjects
    Tatsuo Tomita
    Department of Integrative Bioscience, Oregon National Primate Center, Oregon Health and Science University, Portland, OR, USA
    Islets 3:166-74. 2011
    ..Islet amyloid polypeptide hyposecretion was known in type 1 diabetics and this study aimed to detect possibly reduced islet amyloid polypeptide-positive cells in type 1 diabetic islets...
  9. ncbi Localization of nerve fibers in colonic polyps, adenomas, and adenocarcinomas by immunocytochemical staining for PGP 9.5
    Tatsuo Tomita
    Department of Pathology and Oregon National Primate Center, Oregon Health and Science University, Portland, OR, USA
    Dig Dis Sci 57:364-70. 2012
    ..PGP 9.5 is a cytoplasmic protein and is a specific marker for neurites and neurons...
  10. ncbi Immunocytochemical staining for islet amyloid polypeptide in pancreatic endocrine tumors
    Tatsuo Tomita
    Department of Pathology and Oregon National Primate Center, Oregon Health and Science University, Portland, OR, USA
    Islets 3:344-51. 2011
    ..This study aimed to identify islet amyloid polypeptide by immunocytochemical staining in pancreatic endocrine tumors including 30 cases of insulinomas and non-β-cell pancreatic endocrine tumors...
  11. ncbi Phyllodes tumor of borderline malignancy: seven year follow up with immunohistochemical study
    Tatsuo Tomita
    Division of Surgical Pathology, Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, Kansas, USA
    Pathol Int 55:585-9. 2005
    ..These findings support the notion that Ki-67 and p53 immunohistochemical staining may be used as simple and practical markers for the evaluation of the malignant potential of PT...
  12. ncbi Cyclin-dependent kinase (cdk6) and p16 in pancreatic endocrine neoplasms
    Tatsuo Tomita
    Department of Pathology, Texas Tech Medical Center, El Paso, Texas, USA
    Pathology 36:566-70. 2004
    ..The current study used immunocytochemical staining to compare the staining intensity of cdk6 and its inhibitor, p16, in pancreatic endocrine neoplasms with normal pancreatic islets...
  13. ncbi Amyloidosis of pancreatic islets in primary amyloidosis (AL type)
    Tatsuo Tomita
    Department of Pathology, University of Kansas Medical Center, Kansas City, Kansas, USA
    Pathol Int 55:223-7. 2005
    ..However, considerable islet amyloidosis can be seen in severe AL-type amyloidosis...
  14. ncbi Zygomycosis involving lungs, heart and brain, superimposed on pulmonary edema
    Tatsuo Tomita
    Department of Pathology, Texas Tech University Medical Center, El Paso, Texas, USA
    Pathol Int 55:202-5. 2005
    ..Corticosteroid medication and hemodialysis triggered increasing hyperglycemia, metabolic acidosis and iron overload, which contributed to zygomycosis infection that subsequently spread to the heart and brain as a rare consequence...
  15. ncbi Gastrointestinal stromal tumor of jejunum with angiodysplasia
    T Tomita
    Department of Pathology, Texas Tech University Health Sciences Center, El Paso, Texas, USA
    Dig Dis Sci 49:667-71. 2004
  16. ncbi Immunocytochemical localization of prohormone convertase 1/3 and 2 in pancreatic islet cells and islet cell tumors
    T Tomita
    Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City 66160, USA
    Pancreas 23:172-6. 2001
    ....
  17. ncbi Amylin in pancreatic islets and pancreatic endocrine neoplasms
    Tatsuo Tomita
    Department of Pathology, Texas Tech Medical Center at El Paso, Texas 79905, USA
    Pathol Int 53:591-5. 2003
    ..The lesser immunoreactive amylin in pancreatic endocrine neoplasms than in normal islet cells may contribute to autonomous hypersecretion of hormones by pancreatic endocrine neoplasms...
  18. ncbi Amylin in human pancreatic islets
    T Tomita
    Department of Pathology, University of Kansas Medical Center, Kansas City, Kansas, USA
    Pathology 35:34-6. 2003
    ..Double and triple immunocytochemical staining was used to co-localise amylin with four pancreatic hormones, including insulin, glucagon, somatostatin and pancreatic polypeptide...
  19. ncbi Phyllodes tumor of borderline malignancy: a 7-year follow-up
    T Tomita
    Division of Surgical Pathology, Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, Kansas
    Breast J 9:333-4. 2003
  20. ncbi New markers for pancreatic islets and islet cell tumors
    Tatsuo Tomita
    Department of Pathology, University of Kansas Medical Center, Kansas City, Kansas, USA
    Pathol Int 52:425-32. 2002
    ..Thus, islets not only secrete insulin and other pancreatic hormones but are a complex organ whose major function is glucose homeostasis...
  21. ncbi Immunocytochemical localization of prohormone convertase 1/3 and 2 in gastrointestinal carcinoids
    T Tomita
    Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, 3901 Rainbow Blvd, Kansas City, KS 66160, USA
    Endocr Pathol 12:137-45. 2001
    ..PCs immunocytochemistry may be added as a new phenotypic characterization for gastrointestinal carcinoids...
  22. ncbi Autopsy findings of heart and lungs in a patient with primary pulmonary hypertension associated with use of fenfluramine and phentermine
    Tatsuo Tomita
    Department of Pathology, University of Kansas Medical Center, Kansas City, KS 66160, USA
    Chest 121:649-52. 2002
    ....
  23. ncbi Histidine decarboxylase expression in pancreatic endocrine cells and related tumors
    Akihide Tanimoto
    Department of Pathology, Toranomon Hospital and Okinaka Memorial Institute for Medical Research, Tokyo, Japan
    Pathol Int 54:408-12. 2004
    ..In conclusion, we demonstrated that the majority of pancreatic endocrine tumors expressed HDC, and we suggest that HDC is a wider new marker for neuroendocrine differentiation...